雌激素受体阴性/孕激素受体阳性/人表皮生长因子受体2阴性（ERPRHER2）乳腺癌的临床考量 - Suppr

Suppr

超能文献

Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ERPRHER2) breast cancer.

作者信息

Rala de Paula Bruno Henrique, Crocamo Susanne, Bines Jose

机构信息

Breast Cancer Research Unit, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.

Medical Oncology Department, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.

出版信息

Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023.

DOI:10.21037/tbcr-22-41

PMID:38751458

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11093056/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31d/11093056/aa73104d22d1/tbcr-04-8-f1.jpg

相似文献

Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ERPRHER2) breast cancer.

Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023.

Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.

World J Surg Oncol. 2016 Sep 13;14(1):244. doi: 10.1186/s12957-016-0999-x.

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.

Breast J. 2022 May 17;2022:9238804. doi: 10.1155/2022/9238804. eCollection 2022.

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.

Theranostics. 2018 Dec 8;8(22):6386-6399. doi: 10.7150/thno.29164. eCollection 2018.

Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.

World J Surg. 2015 Oct;39(10):2450-8. doi: 10.1007/s00268-015-3133-2.

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17.

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.

Breast Cancer Res Treat. 2019 Jun;175(2):451-458. doi: 10.1007/s10549-019-05141-y. Epub 2019 Feb 13.

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1534-43. doi: 10.1007/s00259-014-2744-4. Epub 2014 Mar 21.

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.

Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17.

引用本文的文献

Correlation between SWE parameters and histopathological features and immunohistochemical biomarkers in invasive breast cancer.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Dec 28;49(12):1941-1952. doi: 10.11817/j.issn.1672-7347.2024.240398.

Development and validation of a radiomics-based nomogram for predicting two subtypes of HER2-negative breast cancer.

Gland Surg. 2024 Dec 31;13(12):2300-2312. doi: 10.21037/gs-24-325. Epub 2024 Dec 27.

本文引用的文献

High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.

Pathology. 2022 Apr;54(3):269-278. doi: 10.1016/j.pathol.2021.10.003. Epub 2022 Jan 21.

Immunohistochemical and clinicopathologic features of estrogen receptor-negative, progesterone receptor-positive, HER-2 negative breast carcinomas.

Rev Assoc Med Bras (1992). 2021 Feb;67(2):265-270. doi: 10.1590/1806-9282.67.02.20200683.

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.

Clin Breast Cancer. 2020 Apr;20(2):e151-e163. doi: 10.1016/j.clbc.2019.07.002. Epub 2019 Aug 22.

The Value and Future Developments of Multidisciplinary Team Cancer Care.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:332-340. doi: 10.1200/EDBK_236857. Epub 2019 May 17.

Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining.

Breast Cancer. 2019 Mar;26(2):249-254. doi: 10.1007/s12282-018-0898-9. Epub 2018 Jul 31.

Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?

Cancer Treat Rev. 2018 Jun;67:78-87. doi: 10.1016/j.ctrv.2018.05.005. Epub 2018 May 16.

Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.

J Clin Pathol. 2017 Apr;70(4):320-326. doi: 10.1136/jclinpath-2016-203847. Epub 2016 Sep 9.

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.

Breast Cancer Res Treat. 2016 Jan;155(1):85-97. doi: 10.1007/s10549-015-3651-5. Epub 2015 Dec 9.

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.

BMC Med. 2015 Oct 5;13:254. doi: 10.1186/s12916-015-0496-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验